NIDEK launches the RS-1 Glauvas Optical Coherence Tomography
|
NIDEK CO., LTD., a global leader in the design, manufacture, and distribution of ophthalmic, optometric, and lens edging equipment, is pleased to announce the launch of the RS-1 Glauvas Optical Coherence Tomography.
The RS-1 Glauvas is an innovative OCT system with up to 250kHz scan speed, high-quality wide and deep area imaging, great operability, and deep learning-based analytics. With these capabilities, the RS-1 Glauvas provides streamlined workflow and diagnostic confidence for glaucoma and retinal vascular diseases in high-volume clinical practices.
The incorporation of 250,000 A-scans/s accelerates the workflow by reducing capture time. The high-speed imaging also addresses patient fixation errors thus contributing to greater image clarity and patient comfort.
With the capability of wide area imaging, a single B-scan image clearly presents the area from the optic nerve head to the temporal vascular arcade, and the 4.2 mm depth B-scan imaging readily captures the oblate retinal shape of myopic eyes. Improvements in optional AngioScan OCT-Angiography include wider and clearer images for assessing chorioretinal microvasculature.
Great operability contributes to clinic efficiency through multiple features such as auto alignment, preset scanning patterns, user-friendly interface, and diagnostic aid functions allow rapid, easy image capture and interpretation.
The RS-1 Glauvas incorporates various advanced analytics functions for glaucoma and retinal diseases. The long axial length normative database* and scan width correction help glaucoma assessment of patients with axial myopia. Deep learning (DL) segmentation reduces artifacts and errors in the normative database and thickness maps even in eyes with opacities, thus decreasing false positives and enhancing clinic efficiency by reducing unnecessary follow-up visits. The DL segmentation provides a Structural Normality Map (SN Map) developed in collaboration with Kagoshima University. The SN Map presents structural abnormalities and aids clinicians in detecting minute structural changes at a glance, contributing to greater diagnostic confidence even for early signs of retinal changes.
“We
have confidence that the RS-1 Glauvas is an ideal solution for retinal
assessment in high-volume clinical practice.” says Motoki Ozawa,
President and CEO of NIDEK CO., LTD. “The engineering and technical
advances incorporated into the RS-1 Glauvas help address physician and
staff workload by achieving high-speed imaging and excellent
operability. In addition, our innovative analytics functions will
enhance clinical efficiency and diagnostic confidence.”
*Data was collected from a sample of Asian patients.
Product/model name: Optical Coherence Tomography RS-1
Class IIa CE 0344-certified product